FDA updates testosterone labels per TRAVERSE trial. Entvin AI aids pharma with instant comparisons, gap detection & compliant language suggestions.

FDA updates buprenorphine labels removing outdated maximum dose limits and “target dose” language. Entvin’s AI shows what changed, fast.

Label changes reveal competitor strategy and safety trends. Entvin makes tracking them fast, clear, and actionable.

Entvin's latest feature,Ask AI, empowers regulatory professionals by extracting critical insights from FDA review documents, EPARs, and drug labels.

Let’s talk about one of the least understood yet most vital roles in pharma — Regulatory Affairs. From fast approvals to global safety, it’s the secret weapon driving success.

AI-powered Label Version Comparison simplifies CCDS development, uncovering regulatory shifts, RWE insights, and precedent strategies—empowering drug developers and regulatory teams.